Concepedia

Author

Rupak Singla

LRS Institute of Tuberculosis and Respiratory DiseasesORCID

Also Known As

Neeta Singla, R Singla, R. Singla, Rashmi Singla, Ruchit Singla, Rupak Singla

32

Publications

2K

Citations

14

H-Index

34

Concepts

All Affiliations

LRS Institute of Tuberculosis and Respiratory DiseasesHospital Universitario de Gran Canaria Doctor NegrínKarolinska InstitutetHarvard Global Health InstituteGerman Center for Infection Research
RS

About

Rupak Singla is an author at LRS Institute of Tuberculosis and Respiratory Diseases specializing in tuberculosis, medicine, and tuberculosis prevention.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

255

2

Natural Sciences

1

1

114

3

Biochemistry

1

1

114

4

Cell Biology

1

1

61

5

Cellular Physiology

1

1

61

Rupak Singla

×

12

Publications

635

Citations

12

H-Index

YearCitations

Use of Urine Volatile Organic Compounds To Discriminate Tuberculosis Patients from Healthy Subjects

Khalid Muzaffar Banday, Kishore Kumar Pasikanti, Eric Chun Yong Chan,

Analytical Chemistry

2011

114

Seven-year DOTS-Plus pilot experience in India: results, constraints and issues.

Rupak Singla, Rajiv Sarin, Umar Khalid,

PubMed

2009

95

Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment.

Rupak Singla, M M Osman, Nisar Khan,

PubMed

2003

93

Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

S.K. Abidi, Jay Achar, M.M. Assao Neino,

European Respiratory Journal

2019

87

Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India

Rupak Singla, José A. Caminero, Ashish Jaiswal,

European Respiratory Journal

2011

66

Voltage Gated Calcium Channels Negatively Regulate Protective Immunity to Mycobacterium tuberculosis

Shashank Gupta, Nasir Salam, Varsha Srivastava,

PLoS ONE

2009

61

Risk factors for new pulmonary tuberculosis patients failing treatment under the Revised National Tuberculosis Control Programme, India.

Rupak Singla, D Srinath, S Gupta,

PubMed

2009

36

Clinical standards for drug-susceptible pulmonary TB

Onno W. Akkerman, Raquel Duarte, Simon Tiberi,

The International Journal of Tuberculosis and Lung Disease

2022

24

Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results.

Rupak Singla, Sangeetha Gupta, Rahul Gupta,

PubMed

2001

21

Cutaneous tuberculosis caused by multidrug‐resistant tubercle bacilli: report of three cases

V. Ramesh, M. K. Sen, Deepthi Nair,

International Journal of Dermatology

2011

14

Page 1